Literature DB >> 32195773

The Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid Following Intravenous Administration: A Report of Successfully Treated Infant with Mycoplasma hominis Meningitis.

John Nohren1, Katie Namtu2, Charles Peloquin3, Allison Messina4, Gerald Tuite5, David M Berman4.   

Abstract

A female infant underwent myelomeningocele repair and developed persistent ventricular dilatation. Cerebrospinal fluid (CSF) indices demonstrated meningitis with cultures growing Mycoplasma hominis. The infant was treated with multiple antibiotics including moxifloxacin. Moxifloxacin CSF levels were obtained for pharmacokinetic analysis. This case report adds the importance of understanding the pharmacokinetics of CSF moxifloxacin levels among infants.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32195773     DOI: 10.1097/INF.0000000000002655

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  2 in total

1.  Therapeutic Drug Monitoring of Moxifloxacin to Guide Treatment of Mycoplasma hominis Meningitis in an Extremely Preterm Infant.

Authors:  Telford Yeung; Erin Chung; Jennifer Chen; Laura K Erdman; Mina Smiljkovic; Waison Wong; Asaph Rolnitsky; Shaun K Morris; Amr El Shahed; Rudaina Banihani; Ari Bitnun; Christopher Tomlinson
Journal:  J Pediatr Pharmacol Ther       Date:  2021-11-10

2.  Mycoplasma hominis meningitis in an extremely preterm newborn: a case report.

Authors:  Najmus Sehr Ansari; Elizabeth Asztalos; Asaph Rolnitsky
Journal:  BMC Pediatr       Date:  2021-02-08       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.